logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Veronique Plantevin

This inventor holds 5 USPTO granted patents. Top assignee: Signal Pharmaceuticals, Inc.. Active years: 2005-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Veronique Plantevin. Retrieved from https://idiyas.com/inventor/veronique-plantevin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

Average Co-Inventor Count = 8.3

ph-index = 5

Forward Citations = 71(Granted Patents)


Company Filing History:

goldMedal5 out of 169 
 
Signal Pharmaceuticals, Inc.
 patents

Years Active: 2005-2007

Loading Chart...
5 patents (USPTO):Explore Patents
1. 7220771 - Methods of using indazole derivatives as JNK inhibitors (2007-05-22),
2. 7211594 - Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith (2007-05-01),
3. 7208513 - Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith (2007-04-24),
4. 7037936 - Compounds useful for the treatment of cancer, compositions thereof and methods therewith (2006-05-02),
5. 6897231 - Indazole derivatives as JNK inhibitors and compositions and methods related thereto (2005-05-24),

Title: Veronique Plantevin: Innovator in JNK Inhibitors

Introduction

Veronique Plantevin is a prominent inventor based in San Diego, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that act as selective inhibitors of JNK (c-Jun N-terminal kinase). With a total of 5 patents to her name, her work has the potential to impact the treatment of various diseases.

Latest Patents

Among her latest patents, Veronique has developed methods of using indazole derivatives as JNK inhibitors. These compounds are designed to treat a wide range of conditions that respond to JNK inhibition. The patents disclose pharmaceutical compositions containing these indazole derivatives, which have shown utility in treating inflammatory diseases and disorders.

Career Highlights

Veronique Plantevin is currently associated with Signal Pharmaceuticals, Inc., where she continues to innovate in the pharmaceutical sector. Her research focuses on the therapeutic applications of indazole compounds, contributing to advancements in medical treatments.

Collaborations

Throughout her career, Veronique has collaborated with notable colleagues, including Shripad S Bhagwat and Yoshitaka Satoh. These partnerships have further enhanced her research and development efforts in the field.

Conclusion

Veronique Plantevin is a trailblazer in the development of JNK inhibitors, with a strong portfolio of patents that reflect her innovative spirit. Her work at Signal Pharmaceuticals, Inc. continues to pave the way for new treatments in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…